Winner Medical(SZ:300888) Sou Hu Cai Jing·2025-12-11 14:13Core Viewpoint - The stock of Steady Medical (300888) has shown a decline in price and a mixed flow of funds, indicating potential volatility in investor sentiment and market performance [1][2]. Financial Performance - As of the third quarter of 2025, Steady Medical reported a main business revenue of 7.897 billion yuan, a year-on-year increase of 30.1% [3] - The net profit attributable to shareholders was 732 million yuan, up 32.36% year-on-year [3] - The company achieved a single-quarter main business revenue of 2.601 billion yuan in Q3 2025, reflecting a 27.71% increase year-on-year [3] - The gross profit margin stood at 48.32%, which is higher than the industry average of 42.35% [3] Market Position - Steady Medical's total market capitalization is 22.018 billion yuan, ranking 4th in the beauty and personal care industry [3] - The company has the highest net assets in the industry at 12.263 billion yuan, ranking 1st [3] - The price-to-earnings ratio (P/E) is 22.56, which is lower than the industry average of 35.79, ranking 2nd [3] Fund Flow Analysis - On December 11, 2025, the stock experienced a net outflow of main funds amounting to 7.7272 million yuan, which accounted for 8.87% of the total transaction amount [1][2] - Retail investors showed a net inflow of 1.7603 million yuan, representing 2.02% of the total transaction amount on the same day [1][2] - Over the past five days, the stock has seen fluctuating fund flows, with significant net outflows from main funds on multiple days [2] Analyst Ratings - In the last 90 days, 20 institutions have rated the stock, with 17 buy ratings and 3 hold ratings [4] - The average target price set by institutions over the past 90 days is 5.488 billion yuan [4]